AMC Theatres
AMC
$2.07
+5.61%
AMC Entertainment Holdings Inc operates the largest movie theater chain in the United States and Europe, offering traditional and premium theatrical experiences such as IMAX, Dolby Cinema, and dine-in services. As the dominant player in the North American exhibition industry, AMC has leveraged its scale and premium formats to differentiate itself amid shifting consumer habits. The current investor narrative centers on a post-pandemic recovery in box office attendance, but persistent dilution from equity offerings and heavy debt loads have kept the stock under pressure, with recent news highlighting a $200 million equity raise that has reignited concerns over shareholder value destruction.…
AMC
AMC Theatres
$2.07
Related headlines
Investment Opinion: Should I buy AMC Today?
Rating: Sell. AMC's structural dilution and negative free cash flow make it a value trap despite low valuation. The analyst consensus is mixed with 1 Buy, 2 Neutral, and 1 Sell, but the average target is not provided; however, the wide EPS estimate range (-$0.24 to $0.11) reflects high uncertainty. Supporting Evidence: The P/S ratio of 0.17 is near historical lows, but this is justified by negative net income and cash burn. Revenue grew 21% YoY, but sequential decline from Q4 2025 ($1.288B) to Q1 2026 ($1.045B) raises concerns. Gross margin is stable at 69.2%, but operating margin remains negative at -4.27%. Free cash flow is deeply negative, and the company relies on equity offerings. Risks & Conditions: The biggest risks are further dilution, inability to achieve positive FCF, and macro headwinds. This Sell rating would upgrade to Hold if AMC generates positive free cash flow and reduces debt, or downgrade to Strong Sell if another large equity offering is announced. The stock is overvalued relative to its fundamentals because the market cap of $800M does not reflect the negative equity and cash burn.
Sign up to view all
AMC 12-Month Price Forecast
AMC faces a challenging 12-month outlook. The base case of continued losses and dilution is most likely, with a 50% probability. The bear case (30%) is more probable than the bull case (20%) due to structural financial weaknesses. The stock's low P/S ratio is a trap, as negative earnings and cash flow justify the discount. To upgrade to neutral, AMC would need to demonstrate positive free cash flow and halt equity dilution.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AMC Theatres's 12-month outlook, with a consensus price target around $2.24 and implied upside of +8.3% versus the current price.
Average Target
$2.24
0 analysts
Implied Upside
+8.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$1 - $3
Analyst target range
AMC is covered by 5 analysts, with a consensus that leans bearish. The distribution includes 1 Buy (Benchmark), 2 Neutral (Macquarie, Roth Capital), and 1 Sell (Citigroup), with one analyst not explicitly rated. The average target price is not provided, but based on the estimated EPS range of -$0.24 to $0.11 and revenue estimates around $5.96 billion, the implied upside/downside cannot be calculated without target prices. However, the recent downgrade from Benchmark from Hold to Buy and the consistent Sell rating from Citigroup indicate mixed sentiment. The lack of a clear consensus target suggests uncertainty. The target range is not available, but the wide EPS estimate range (-$0.24 to $0.11) implies high uncertainty about the company's near-term profitability. The high EPS estimate of $0.11 would require a significant turnaround, while the low estimate of -$0.24 suggests continued losses. The limited analyst coverage and wide estimate spread indicate that AMC remains a high-risk, high-volatility stock with low institutional conviction.
Drowning in data?
Find the real signal!
Bulls vs Bears: AMC Investment Factors
AMC presents a high-risk, high-reward profile. The bull case rests on a post-pandemic recovery in box office attendance, deeply discounted valuation (P/S 0.17), and improving loss trends. However, persistent shareholder dilution, negative equity, and cash burn create severe headwinds. The single most important tension is whether revenue growth can outpace dilution and debt costs to achieve sustainable profitability. Currently, bearish evidence is stronger due to the structural overhang of equity offerings and negative free cash flow.
Bullish
- Revenue Growth Accelerating: Q1 2026 revenue of $1.045B grew 21.2% YoY from $862.5M, driven by strong box office attendance. This demonstrates post-pandemic recovery momentum.
- Deeply Discounted Valuation: Trailing P/S ratio of 0.17 is near historical lows, implying the market prices in severe distress. If AMC returns to profitability, multiple expansion could yield significant upside.
- Improving Loss Trajectory: Net loss narrowed from -$202.1M in Q1 2025 to -$117.1M in Q1 2026, a 42% improvement. Operating loss also reduced from -$142.7M to -$44.6M.
- Strong Summer Box Office: Recent news highlights strong summer attendance, supporting Q2 2026 revenue. The stock bounced from $0.93 low to $2.07, reflecting improved sentiment.
Bearish
- Persistent Dilution from Equity Raises: AMC issued $63.4M in common stock in Q1 2026 alone, and a $200M equity offering was announced in July 2026. Share count has grown from 431M to 540M in one year, destroying per-share value.
- Negative Equity and High Leverage: Debt-to-equity ratio of -4.29 indicates negative shareholders' equity. Total debt exceeds assets, making the company technically insolvent on a book basis.
- Cash Burn and Negative Free Cash Flow: Trailing twelve-month free cash flow is -$123.6M, and Q1 2026 FCF was -$174.7M. The company relies on external financing to operate.
- Uncertain Profitability Path: Despite revenue growth, operating margin was -4.27% in Q1 2026. High fixed costs and interest expense ($139.9M per quarter) keep the company unprofitable.
AMC Technical Analysis
AMC is in a clear downtrend over the past year, with the stock declining 33.65% despite a recent bounce. The current price of $2.07 sits at 43.8% of its 52-week range ($0.93 low to $3.60 high), indicating it is closer to the low end and suggesting a potential value opportunity, though the long-term trend remains bearish. The 1-year relative strength versus SPY is -54.97%, confirming significant underperformance. Short-term momentum has improved, with a 3-month gain of 28.57% and a 6-month gain of 28.57%, but the 1-month change is -9.21%, showing a recent pullback. This divergence between the short-term recovery and the longer-term downtrend could signal a temporary bounce within a larger bearish pattern, or a potential trend reversal if the stock can sustain above key levels. The RSI is not provided, but the recent price action from a low of $0.93 in March to $2.07 suggests a strong recovery, though the July decline from $2.83 to $2.07 indicates resistance. The 52-week high of $3.60 represents a major resistance level; a breakout above that would signal a significant reversal. The 52-week low of $0.93 is key support; a breakdown below that would likely accelerate losses. With a beta of 2.277, AMC is 127.7% more volatile than the S&P 500, meaning it amplifies market moves and requires careful risk management.
Beta
2.28
2.28x market volatility
Max Drawdown
-73.2%
Largest decline past year
52-Week Range
$1-$4
Price range past year
Annual Return
-33.7%
Cumulative gain past year
| Period | AMC Return | S&P 500 |
|---|---|---|
| 1m | -9.2% | +0.6% |
| 3m | +28.6% | +6.3% |
| 6m | +28.6% | +9.1% |
| 1y | -33.7% | +20.9% |
| ytd | +28.6% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AMC Fundamental Analysis
Revenue in Q1 2026 was $1.045 billion, up 21.21% year-over-year from $862.5 million in Q1 2025, indicating a strong recovery in box office attendance. However, revenue has declined sequentially from $1.288 billion in Q4 2025, and the multi-quarter trend shows volatility: Q2 2025 revenue was $1.398 billion, Q3 2025 was $1.300 billion, and Q4 2025 was $1.288 billion. The growth is driven by admissions ($578.4 million) and food & beverage ($347.3 million), but the sequential decline raises questions about sustainability. The company remains unprofitable, with a net loss of $117.1 million in Q1 2026, though this is an improvement from the $202.1 million loss in Q1 2025. Gross margin was 69.2% in Q1 2026, relatively stable, but operating margin was -4.27%, indicating high fixed costs. Net margin was -11.2%, and the trailing twelve-month free cash flow was -$123.6 million, showing the company is still burning cash. AMC's balance sheet is highly leveraged, with a debt-to-equity ratio of -4.29 (negative equity), a current ratio of 0.41, and cash of $380.9 million at the end of Q1 2026. Free cash flow was -$174.7 million in Q1 2026, and the company relies on equity offerings to fund operations, as seen in the $63.4 million in common stock issued during the quarter. The negative equity and high debt levels pose significant financial risk.
Quarterly Revenue
$1.0B
2026-03
Revenue YoY Growth
+21.2%
YoY Comparison
Gross Margin
69.2%
Latest Quarter
Free Cash Flow
$-123600000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AMC Overvalued?
Since AMC has negative net income, the P/E ratio is not meaningful. Therefore, we use the price-to-sales (P/S) ratio as the primary valuation metric. The trailing P/S ratio is 0.17, based on a market cap of $800 million and trailing twelve-month revenue of approximately $4.7 billion. This is extremely low, suggesting the market is pricing in significant risk or future revenue declines. The EV/Sales ratio is 1.75, which is more relevant given the company's debt load. Compared to the industry average (not provided), a P/S of 0.17 is likely a deep discount, but this reflects the company's negative earnings and high leverage. Historically, AMC's P/S ratio has ranged from 0.5 to over 100 during the meme stock era. The current P/S of 0.17 is near the bottom of its historical range, indicating that the market is pricing in a pessimistic outlook. The forward P/E is -12.94, confirming continued losses expected. The low valuation suggests either a deep value opportunity if the company can return to profitability, or a value trap if structural challenges persist.
PE
-1.3x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
39.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: AMC's balance sheet is severely strained, with a debt-to-equity ratio of -4.29 and a current ratio of 0.41, indicating liquidity risk. The company burned $174.7M in free cash flow in Q1 2026, and trailing twelve-month FCF is -$123.6M. Interest expense of $139.9M per quarter consumes a large portion of gross profit ($723.4M in Q1 2026). The negative equity means the company has no book value cushion, making it vulnerable to any downturn. Market & Competitive Risks: AMC's beta of 2.277 makes it highly sensitive to market downturns, amplifying losses. The stock has underperformed the S&P 500 by 55% over the past year. Competition from streaming services and changing consumer habits pose secular threats. The recent $200M equity offering signals that the company cannot fund operations internally, which may further depress the stock. Worst-Case Scenario: If box office attendance disappoints or another equity raise is announced, the stock could fall to its 52-week low of $0.93, representing a 55% decline from the current price of $2.07. In a severe recession, the stock could drop below $0.50, implying a 76% loss from current levels, as the company may face bankruptcy risk.
FAQ
The key risks are: 1) Dilution: AMC raised $63.4M in Q1 2026 and announced a $200M equity offering, which destroys shareholder value. 2) Financial distress: Debt-to-equity of -4.29 and negative free cash flow of -$123.6M TTM indicate potential bankruptcy risk. 3) Macro sensitivity: Beta of 2.277 means the stock amplifies market downturns. 4) Industry disruption: Streaming services and changing consumer habits threaten box office attendance long-term. The most severe risk is a liquidity crisis that forces a dilutive restructuring.
The 12-month forecast is bearish with a base case target of $1.50-$2.50 (50% probability), assuming continued losses and dilution. The bull case (20% probability) targets $3.00-$3.60 if AMC achieves near-profitability and pauses equity raises. The bear case (30% probability) sees the stock falling to $0.50-$1.00 due to recession or further dilution. The most likely scenario is the base case, where the stock trades in a range as the company struggles to generate positive free cash flow.
AMC appears undervalued on a price-to-sales basis (P/S 0.17), but this metric is misleading because the company is unprofitable and has negative equity. The EV/Sales ratio of 1.75 is more relevant given the debt load, and it is not cheap compared to historical levels. The negative P/E and forward P/E of -12.94 confirm that the market expects continued losses. Relative to peers, AMC trades at a discount, but this is justified by its financial distress. The valuation implies the market expects either a turnaround or further deterioration, making it a high-risk binary bet.
AMC is not a good buy for most investors due to its negative equity, persistent dilution, and cash burn. The stock has a trailing P/S of 0.17, which appears cheap, but this reflects the market's expectation of continued losses. Analyst sentiment is mixed, with a wide EPS estimate range of -$0.24 to $0.11, indicating high uncertainty. The biggest downside risk is further dilution from equity offerings, which could push the stock below $1.00. For aggressive traders with a high risk tolerance, a short-term trade based on box office momentum might work, but long-term holding is not recommended.
AMC is suitable only for short-term trading due to its high volatility (beta 2.277) and structural financial problems. The stock has no dividend and negative earnings, making it unattractive for long-term holding. The company's negative equity and reliance on equity offerings suggest that long-term shareholders will face significant dilution. A short-term trade based on box office catalysts (e.g., summer movie releases) could yield gains, but the risk of a sharp decline is high. A minimum holding period of a few weeks to months is recommended, with strict stop-losses.
